Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003060 · ClinicalTrials.gov registry record · Phase 1
Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Metastatic Melanoma
A Phase 1 study, sponsored by Louisiana State University Health Sciences Center Shreveport.
- Terminated
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT00003060 is a Phase 1 study that was terminated before completion, run by Louisiana State University Health Sciences Center Shreveport. The registered enrollment target is 6 participants.
The verdict
NCT00003060, a Phase 1 study, was terminated before completion, sponsored by Louisiana State University Health Sciences Center Shreveport.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with bone marrow transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: Clinical trial to study the effectiveness of chemotherapy plus bone marrow transplantation in treating patients with metastatic melanoma that has not responded to previous therapy.
Interventions
- DRUG cyclophosphamide
- DRUG methotrexate
- BIOLOGICAL filgrastim
- DRUG busulfan
- DRUG cyclosporine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 1995-03 |
| Est. Completion | 2001-02-22 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00003060
The ClinicalTrials.gov registry entry for NCT00003060 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Louisiana State University Health Sciences Center Shreveport, which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which cyclophosphamide is the first listed.
NCT00003060 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00003060 about?
NCT00003060 is a clinical study titled "Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Metastatic Melanoma". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with bone marrow transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: Clinical trial to study...
What is the current status of trial NCT00003060?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 1995-03. Estimated completion is 2001-02-22.
What interventions are being tested in trial NCT00003060?
The interventions under investigation include: cyclophosphamide (DRUG), methotrexate (DRUG), filgrastim (BIOLOGICAL), busulfan (DRUG), cyclosporine (DRUG).
Who is sponsoring clinical trial NCT00003060?
This trial is sponsored by Louisiana State University Health Sciences Center Shreveport, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.